STARGATE is an additional venture and part of the Ebenhaezer Bank Consulting Group’s Mining and Commodity Trading Division. The STARGATE group is proud of its many diversification projects, and one such diversification is BIOTECH and the development of MOKA-19. In these challenging times partnerships are needed to address the unprecedented novel coronavirus (SARS-CoV-2), and so in an effort to stay current with the latest updates from a team of healthcare and medical professionals, we have sought to forge partnerships with Medscape, Elabscience, Clungene and Proven Pharma.
25 YEARS OF MEDSCAPE
As Medscape enters its 25th year, COVID-19 is challenging the medical community both professionally and personally. STARGATE is proud to expand its diversification program to our BIOTECH DIVISION as we partner with MEDSCAPE to address the Coronavirus Pandemic affecting the world's population.
Our current world-wide pandemic has proven to be quite a challenge, that our scientist and bioengineers are rushing now to find a vaccine against COVID-19.
In the meanwhile, many countries, regions, and communities are trying to provide test to as many of its residents and this is proving to be an enormous challenge.
Well STARGATE has the answer, no more long waiting for testing results, no longer do you have to wait days or weeks to find out if you are positive or negative.
MOKA-19 is here! The 2-10-minute test kit.